spacer
spacer

References

  1. Caputo R. Itraconazole (Sopranox) in superficial and systemic fungal infections. Expert Rev Anti Infect Ther 2003;1:531-542.
  2. Chu AC. Comparative clinical trial of bifonazole solution versus selenium sulphide shampoo in the treatment of pityriasis versicolor. Dermatologica 1984;169(Suppl 1):81-86.
  3. Collier CN, Cantrell WC, Elewski BE. Treatment of intertrigo. Poster presented at 65th Annual Meeting of American Academy of Dermatology; Washington DC; February 2-6, 2007.
  4. Current Medical Diagnosis & Treatment 2007. Forty-sixth edition. McPhee SJ, Papadakis MA, Tierney LM, editors. New York: McGraw-Hill, 2007.
  5. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993;29:1008-1012.
  6. Doctor Fungus. Tinea corporis, tinea cruris, and tinea pedis. http://www.doctorfungus.org/mycoses/human/other/TineaCorporis_Cruruis_Pedis.htm Accessed 2/14/2007.
  7. Dupuy P, Maurette C, Amoric JC, Chosidow O; Study Investigator Group. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis. Br J Dermatol 2001;144:1033-1037.
  8. Efalith Multicenter Trial Group. A double-blind, placebo-conotrolled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 1992;26(3 Pt 2):452-457.
  9. Faergemann J. Current treatment of cutaneous Pityrosporum and Candida infections. Acta Derm Venereol Suppl (Stockh) 1986;121:109-116. [A]
  10. _________. Seborrhoeic dermatitis and Pityrosporum orbiculare: Treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 1986;114:695-700. [B]
  11. __________. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol 2000;1:75-80.
  12. Faergemann J, Jones JC, Hettler O, Loria Y. Pityrosporum ovale (Malassezia furfur) as the causative agent of serborrhoeic dermatitis: New treatment options. Br J Dermatol 1996;134(Suppl 46):discussion 38.
  13. Ford GP, Farr PM, Ive FA, Shuster S. The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol 1984;111:603-607.
  14. Gupta AK, Kohli Y, Summerbell RC, Faergemann J. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001;39:243-251.
  15. Gupta AK, Skinner AR, Cooper EA. Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel.
  16. Int J Dermatol 2003;42(Suppl 1):23-27.
  17. Janniger CK, Schwartz RA, Szepietowski JC, Reich A. Intertrigo and common secondary skin infections. Am Fam Physician 2005;72:833-838, 840. http://222.aafp.org/afp/20050901/833.html Accessed 1/5/2007
  18. Leyden JJ. Progression of interdigital infections from simplex to complex. J Am Acad Dermatol 1993;28(5 Pt 1):S7-S11 [abstract].
  19. Leyden JJ, Kligman AM. Interdigital athlete’s foot. The interaction of dermatophytes and resident bacteria. Arch Dermatol 1978;114:1466-1472 [abstract].
  20. Liebel F, Lyte P, Garay M, Babad J, Southall MD. Anti-inflammatory and anti-itch activity of sertaconazole nitrate. Arch Dermatol Res 2006;298:191-199.
  21. Ling MR. Topical tacrolimus and pimecrolimus: Future directions. Semin Cutan Med Surg 2001;20:268-274.
  22. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol 1975;64:401-405.
  23. MedLine Plus. Medical encyclopedia: Seborrheic dermatitis. http://www.nlm.nih.gov/medlineplus/print/ency/article/000963.htm Accessed 4/4/2007
  24. Parsad D, Pandhi R, Negi KS, Kumar B. Topical metronidazole in seborrheic dermatitis—a double-blind study. Dermatology 2001;202:35-37.
  25. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: Results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol 1995;132:441-445.
  26. Phillips RM, Rosen T. Topical antifungal agents. In: Wolverton SE, ed. Comprehensive Dermatologic Drug Therapy. 2nd edition. Wolverton SE, editor. Philadelphia, Pa: Saunders Elsevier; 2007:547-568.
  27. Piaquadio D, Kligman A. The critical role of the vehicle to therapeutic efficacy and patient compliance. J Am Acad Dermatol 1998;39:S67-S73.
  28. Scaparro E, Quadri G, Virno G, Orifici C, Milani M. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial. Br J Dermatol 2001;144:854-857.
  29. Sigle HC, Schafer-Korting M, Korting HC, Hube B, Niewerth M. In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans. Mycoses 2006;49:159-168 [abstract]
  30. Squire RA, Goode K. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%) or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis. J Dermatolog Treat 2002;13:51-60.
  31. Stratigos JD, Antoniou C, Katsambas A, Bohler K, Fritsch P, Schmolz A, Michaelidis D, De Beule K. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative study. J Am Acad Dermatol 1988;19(5 Pt 1):850-853.
  32. Sugita T, Tajima M, Ito T, Saito M, Tsuboi R, Nishikawa A. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol 2005;43:2824-2829.
  33. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician 2002;65:2095-2102.
    http://www.aafp.org/afp.20020515/2095.html Accessed 2/14/2007.
  34. Zhang AY, Camp WL, Elewski BE. Advances in topical and systemic antifungals. Dermatol Clin 2007;25:165-185.

 
spacer
spacer